Publicaciones (14) Publicaciones de María Lourdes Aguilar Sánchez

2023

  1. Prevalence of hepatitis C virus infection in patients with chronic mental disorders: The relevance of dual disorders

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 171-177

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  2. Healthcare professionals' perception and satisfaction with mental health tele-medicine during the COVID-19 outbreak: A real-world experience in telepsychiatry

    Frontiers in Psychiatry, Vol. 13

  3. Increased incidence of high-lethality suicide attempts after the declaration of the state of alarm due to the COVID-19 pandemic in Salamanca: A real-world observational study

    Psychiatry Research, Vol. 312

  4. Tratamiento farmacológico

    Manual de conductas adictivas: Teoría, evaluación y tratamiento (Pirámide), pp. 203-219

2021

  1. A real-world ten-week follow-up of the COVID outbreak in an outpatient drug clinic in Salamanca (Spain)

    Journal of Substance Abuse Treatment, Vol. 125

  2. Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: A systematic review

    European Review for Medical and Pharmacological Sciences, Vol. 25, Núm. 13, pp. 4554-4562

2020

  1. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review

    Reproductive Health, Vol. 17, Núm. 1

  2. Imagen

    Manual de trastornos adictivos (J. Belarmino Bobes, M. Casas y M. Gutiérrez), pp. 73-86

  3. The Impact of COVID-19 Pandemic on the Castile and Leon Addiction Treatment Network: A Real-Word Experience

    Frontiers in Psychiatry, Vol. 11

  4. The relevance of dual diagnoses among drug-dependent patients with sleep disorders

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-13

2019

  1. Mood disorders and severity of addiction in alcohol-dependent patients could be mediated by sex differences

    Frontiers in Psychiatry, Vol. 10, Núm. MAY

  2. Tardive dyskinesia after aripiprazole treatment that improved with tetrabenazine, clozapine, and botulinum toxin

    Frontiers in Pharmacology, Vol. 10, Núm. MAR

2018

  1. Cannabis consumption and psychosis or schizophrenia development

    International Journal of Social Psychiatry, Vol. 64, Núm. 7, pp. 690-704